Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001698530-24-000126
Filing Date
2024-11-26
Accepted
2024-11-26 15:08:26
Documents
1
Period of Report
2024-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1732651699.html 3  
1 FORM 3 wk-form3_1732651699.xml 3 1551
  Complete submission text file 0001698530-24-000126.txt   3022
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address
Baik Seung Ik (Reporting) CIK: 0002045353 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39011 | Film No.: 241502505